- Report
- October 2025
- 197 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 185 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- November 2025
- 177 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 194 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2141EUR$2,400USD£1,888GBP
€2677EUR$3,000USD£2,360GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €1785EUR$2,000USD£1,574GBP
€2231EUR$2,500USD£1,967GBP
- Report
- December 2024
- 152 Pages
Global
From €2820EUR$3,160USD£2,486GBP
€3524EUR$3,950USD£3,108GBP
- Report
- May 2025
- 196 Pages
Global
From €4238EUR$4,750USD£3,737GBP
- Report
- August 2025
- 136 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- April 2025
- 186 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- July 2025
- 82 Pages
United States
From €3123EUR$3,500USD£2,754GBP
- Report
- May 2025
- 120 Pages
Global
From €5309EUR$5,950USD£4,681GBP
- Report
- August 2025
- 183 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 184 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1428EUR$1,600USD£1,259GBP
€1785EUR$2,000USD£1,574GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more